| CTRI Number |
CTRI/2025/08/093645 [Registered on: 25/08/2025] Trial Registered Prospectively |
| Last Modified On: |
|
| Post Graduate Thesis |
No |
| Type of Trial |
Observational |
|
Type of Study
|
Cohort Study |
| Study Design |
Other |
|
Public Title of Study
|
Breast Cancer treatment cost and access to care |
|
Scientific Title of Study
|
Catastrophic costs and expenditure and referral pathways influence treatment of Breast cancer in India |
| Trial Acronym |
Crocodile B |
|
Secondary IDs if Any
|
| Secondary ID |
Identifier |
| version 1.6 Dated10/07/2025 |
Other |
|
|
Details of Principal Investigator or overall Trial Coordinator (multi-center study)
|
| Name |
Dr Deepak Jain |
| Designation |
Assistant Professor |
| Affiliation |
Christian Medical College & Hospital Ludhiana |
| Address |
Department of General Surgery
First floor, Room no 1137, Brown Road, Ludhiana
Ludhiana PUNJAB 141008 India |
| Phone |
9646212700 |
| Fax |
|
| Email |
drjaindj1985@gmail.com |
|
Details of Contact Person Scientific Query
|
| Name |
Dr Deepak Jain |
| Designation |
Assistant Professor |
| Affiliation |
Christian Medical College & Hospital Ludhiana |
| Address |
Department of General Surgery
First floor, Room no 1137, Brown Road, Ludhiana
PUNJAB 141008 India |
| Phone |
9646212700 |
| Fax |
|
| Email |
drjaindj1985@gmail.com |
|
Details of Contact Person Public Query
|
| Name |
Dr Deepak Jain |
| Designation |
Assistant Professor |
| Affiliation |
Christian Medical College & Hospital Ludhiana |
| Address |
Department of General Surgery
First floor, Room no 1137, Brown Road, Ludhiana
PUNJAB 141008 India |
| Phone |
9646212700 |
| Fax |
|
| Email |
drjaindj1985@gmail.com |
|
|
Source of Monetary or Material Support
|
| Non funded study.
The study is coordinated by the Department of General Surgery and India Hub NIHR Global Health Research Unit on Global Surgery, Christian Medical College & Hospital Ludhiana, Brown Road 141008 Punjab |
|
|
Primary Sponsor
|
| Name |
Christian Medical College & Hospital Ludhiana |
| Address |
Christian Medical College & Hospital Ludhiana, Brown Road, 141008, Punjab |
| Type of Sponsor |
Research institution |
|
|
Details of Secondary Sponsor
|
|
|
Countries of Recruitment
|
India |
|
Sites of Study
|
| No of Sites = 2 |
| Name of Principal
Investigator |
Name of Site |
Site Address |
Phone/Fax/Email |
| Dr Deepak Jain |
Christian Medical College Hospital Ludhiana |
Department of General Surgery, First Floor, room no 1137, Brown Road, Ludhiana 141008 Ludhiana PUNJAB |
9646212700
drjaindj1985@gmail.com |
| Dr Fazlul Qadir Parray |
Sher-I- Kashmir Institute of Medical Sciences Srinagar |
Department of General Surgery, 1st Floor main building room no 2301 srinagar Srinagar JAMMU & KASHMIR |
9419008550
fazlparray@rediffmail.com |
|
|
Details of Ethics Committee
|
| No of Ethics Committees= 2 |
| Name of Committee |
Approval Status |
| Institutional Ethics Committee |
Submittted/Under Review |
| Institutional Ethics Committee CMC Ludhiana |
Approved |
|
|
Regulatory Clearance Status from DCGI
|
|
|
Health Condition / Problems Studied
|
| Health Type |
Condition |
| Patients |
(1) ICD-10 Condition: C509||Malignant neoplasm of breast of unspecified site, |
|
|
Intervention / Comparator Agent
|
| Type |
Name |
Details |
| Intervention |
Nil |
Nil |
|
|
Inclusion Criteria
|
| Age From |
18.00 Year(s) |
| Age To |
99.00 Year(s) |
| Gender |
Female |
| Details |
1) Adult aged 18 years to 99 Years
2) Consecutive new patients with a histopathology proven breast cancer for whom a CRC treatment plan is made:
o In a multi-disciplinary team meeting (MDT).
o OR in the outpatient clinic where an MDT is not available (surgery, chemotherapy, or radiation therapy outpatient clinic).
3) Undergoing treatment in the hospital where the MDT took place.
4) Participants must be able to provide written informed consent (signature or a fingerprint). |
|
| ExclusionCriteria |
| Details |
1) Patients with no histopathology available.
2) Patients suffering from double primary cancers
3) Patients for whom a treatment plan is made at recurring hospitals who undergo the full course of treatment in another hospital will be excluded.
4) Patient on Palliative therapy
5) Telephone follow-up not possible. |
|
|
Method of Generating Random Sequence
|
Not Applicable |
|
Method of Concealment
|
Not Applicable |
|
Blinding/Masking
|
Not Applicable |
|
Primary Outcome
|
| Outcome |
TimePoints |
The primary outcome of this study will be catastrophic expenditure at 3 months, 6
months and 1 year after the treatment decision. |
The primary outcome of this study will be catastrophic expenditure at 3 months, 6
months and 1 year after the treatment decision. |
|
|
Secondary Outcome
|
| Outcome |
TimePoints |
1. Treatment compliance rate at 3 months, 6 months and at 1 year after treatment
decision.
2. The five most expensive items comprising breast cancer treatment costs. |
At 3 months, 6 months and at 1 year after treatment |
|
|
Target Sample Size
|
Total Sample Size="1030" Sample Size from India="1030"
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" |
|
Phase of Trial
|
N/A |
|
Date of First Enrollment (India)
|
25/08/2025 |
| Date of Study Completion (India) |
Applicable only for Completed/Terminated trials |
| Date of First Enrollment (Global) |
Date Missing |
| Date of Study Completion (Global) |
Applicable only for Completed/Terminated trials |
|
Estimated Duration of Trial
|
Years="1" Months="6" Days="0" |
|
Recruitment Status of Trial (Global)
|
Not Applicable |
| Recruitment Status of Trial (India) |
Not Yet Recruiting |
|
Publication Details
|
N/A |
|
Individual Participant Data (IPD) Sharing Statement
|
Will individual participant data (IPD) be shared publicly (including data dictionaries)?
Response - NO
|
|
Brief Summary
|
Catastrophic costs and expenditure and referral pathways
influence treatment of Breast cancer in India: (CROCODILE-B)
The aim of the study is to identify financial and
non-financial barriers to comply with treatment for breast cancer in India. The
study will be a mixed-methods study comprising quantitative data from up to 10
tertiary hospitals and qualitative work from interviews with patients and
healthcare professionals where the outcome is the incidence of catastrophic
expenditure due to out-of-pocket payments for cancer care at 3 months and 6
months and 1 year after breast cancer diagnosis. A mixed method study is being
done as we are looking at identifying barriers to adherence to therapy as well
as the patient’s ability to cope with the costs of treatment.
Study Setting and design: This study will be run in ten
hospitals in India where cancer treatment is available and routinely delivered.
This will be a prospective, multicentric, mixed-methods study with two main
workstream: 1. Quantitative workstream: a prospective cohort study to determine
the catastrophic expenditure 2. Qualitative workstream: to explore patient and
professionals perspectives about the barriers to breast cancer treatment
compliance.
The primary objective of this study is to identify the
proportion of breast cancer patients suffering catastrophic expenditure due to
out-of-pocket payments for cancer treatments. The secondary objectives are: 1.
To assess the catastrophic expenditure rate at 3 months, 6 months and 1 year
after diagnosis. 2. To identify the main drivers of treatment costs in breast
cancer treatment.
Sample size: 1030 patients
Duration: 01 year 6 months
Statistical Analysis
All analyses will be conducted using the intention to treat
(ITT) principle, which means that patients’ outcomes will be examined in
relation to their initial treatment plan (surgery, chemotherapy, radiotherapy).
Summary statistics will be supplied for all outcome measures using counts and
percentages for categorical variables and means and standard deviations and/or
medians and interquartile ranges for continuous variables. To test for
differences across comparisons of categorical variables, the Chi square test
will be utilized. Welch’s t-test or ANOVA will be used for continuous data that
is parametric in character (as visually appraised). The Wilcoxon rank sum or
Kruskall-Wallis tests will be employed for non-parametric data. All the
analysis will be undertaken using the R studio software (v2023.12.0+369). |